Dominant negative effects of human follicle-stimulating hormone receptor expression-deficient mutants on wild-type receptor cell surface expression. Rescue of oligomerization-dependent defective receptor expression by using cognate decoys

Molecular and Cellular Endocrinology

Volumn 321, Issue 2, 2010, Pages 112-122

  Zariñán, Teresa ^a   Perez Solís, Marco A ^a   Maya Núñez, Guadalupe ^a   Casas González, Patricia ^a   Conn, P Michael ^a,b   Dias, James A ^c,d   Ulloa Aguirre, Alfredo ^a,b  

^a Hospital Luis Castelazo Ayala   (Mexico)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c WADSWORTH CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Decoy; Dimerization; Dominant negative receptor; Endoplasmic reticulum; Follicle stimulating hormone receptor; Intracellular trafficking

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; THYROTROPIN RECEPTOR; CELL SURFACE RECEPTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL TRANSPORT; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; WILD TYPE; AMINO ACID SEQUENCE; CELL LINE; DIMERIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN FOLDING; RECEPTORS, CELL SURFACE; RECEPTORS, FSH;

EID: 77951258353     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.027     Document Type: Article

References (79)

1. Balasubramanian S., Teissere J.A., Raju D.V., Hall R.A. Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking. J. Biol. Chem. 2004, 279:18840-18850.
2. Beaumont K.A., Shekar S.N., Newton R.A., James M.R., Stow J.L., Duffy D.L., Sturm R.A. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum. Mol. Genet. 2007, 16:2249-2260.
3. Benkirane M., Jin D.Y., Chun R.F., Koup R.A., Jeang K.T. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J. Biol. Chem. 1997, 272:30603-30606.
4. Bogerd J. Ligand-selective determinants in gonadotropin receptors. Mol. Cell. Endocrinol. 2007, 260-262:144-152.
5. Breit A., Lagace M., Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J. Biol. Chem. 2004, 279:28756-28765.
6. Brothers S.P., Cornea A., Janovick J.A., Conn P.M. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect. Mol. Endocrinol. 2004, 18:1787-1797.
7. Bulenger S., Marullo S., Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 2005, 26:131-137.
8. Calebiro D., de Filippis T., Lucchi S., Covino C., Panigone S., Beck-Peccoz P., Dunlap D., Persani L. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum. Mol. Genet. 2005, 14:2991-3002.
9. Cameron M.R., Foster J.S., Bukovsky A., Wimalasena J. Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5′-monophosphates in porcine granulosa cells. Biol. Reprod. 1996, 55:111-119.
10. Cheung A.H., Huang R.R., Graziano M.P., Strader C.D. Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the beta-adrenergic receptor. FEBS Lett. 1991, 279:277-280.
11. Dalrymple M.B., Pfleger K.D., Eidne K.A. G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol. Ther. 2008, 118:359-371.
12. Dias J.A., Cohen B.D., Lindau-Shepard B., Nechamen C.A., Peterson A.J., Schmidt A. Molecular, structural, and cellular biology of follitropin and follitropin receptor. Vitam. Horm. 2002, 64:249-322.
13. Dong Ch., Filipeanu C.M., Duvernay M.T., Wu W. Regulation of G protein-coupled receptor export trafficking. Biochim. Biophys. Acta 2007, 1768:853-870.
14. Duvernay M.T., Zhou F., Wu G. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 2004, 279:30741-30750.
15. Fan T., Varghese G., Nguyen T., Tse R., O'Dowd B.F., George S.R. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J. Biol. Chem. 2005, 280:38478-38488.
16. Gehret A.U., Bajaj A., Naider F., Dumont M.E. Oligomerization of the yeast alpha-factor receptor: implications for dominant negative effects of mutant receptors. J. Biol. Chem. 2006, 281:20698-20714.
17. Gonzalez-Robayna I.J., Falender A.E., Ochsner S., Firestone G.L., Richards J.S. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol. Endocrinol. 2000, 14:1283-1300.
18. Grosse R., Schoneberg T., Schultz G., Gudermann T. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor. Mol. Endocrinol. 1997, 11:1305-1318.
19. Guan R., Feng X., Wu X., Zhang M., Zhang X., Hebert T.E., Segaloff D.L. Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization. J. Biol. Chem. 2009, 284:7483-7494.
20. Guan R., Wu X., Feng X., Zhang M., Hébert T.E., Segaloff D.L. Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell. Signal. 2010, 22:247-256.
21. Hebert T.E., Moffett S., Morello J.P., Loisel T.P., Bichet D.G., Barret C., Bouvier M. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 1996, 271:16384-16392.
22. Huckle W.R., Conn P.M. Use of lithium ion in measurement of stimulated pituitary inositol phospholipid turnover. Methods Enzymol. 1987, 141:149-155.
23. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., Tang C., Shen Q., Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A., Branchek T.A., Gerald C. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998, 396:674-679.
24. Karpa K.D., Lin R., Kabbani N., Levenson R. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol. Pharmacol. 2000, 58:677-683.
25. Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., Mosbacher J., Bischoff S., Kulik A., Shigemoto R., Karschin A., Bettler B. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396:683-687.
26. Kelton C.A., Cheng S.V., Nugent N.P., Schweickhardt R.L., Rosenthal J.L., Overton S.A., Wands G.D., Kuzeja J.B., Luchette C.A., Chappel S.C. The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells. Mol. Cell. Endocrinol. 1992, 89:141-151.
27. Le Gouill C., Parent J.L., Caron C.A., Gaudreau R., Volkov L., Rola-Pleszczynski M., Stankova J. Selective modulation of wild type receptor functions by mutants of G-protein-coupled receptors. J. Biol. Chem. 1999, 274:12548-12554.
28. Leaños-Miranda A., Ulloa-Aguirre A., Ji T.H., Janovick J.A., Conn P.M. Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans. J. Clin. Endocrinol. Metab. 2003, 88:3360-3367.
29. Leaños-Miranda A., Ulloa-Aguirre A., Janovick J.A., Conn P.M. In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles. J. Clin. Endocrinol. Metab. 2005, 90:3001-3008.
30. Lee S.P., O'Dowd B.F., Ng G.Y., Varghese G., Akil H., Mansour A., Nguyen T., George S.R. Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol. Pharmacol. 2000, 58:120-128.
31. Lee S.P., O'Dowd B.F., Rajaram R.D., Nguyen T., George S.R. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 2003, 42:11023-11031.
32. Li S., Liu X., Ascoli M. p38JAB1 binds to the intracellular precursor of the lutropin/choriogonadotropin receptor and promotes its degradation. J. Biol. Chem. 2000, 275:13386-13393.
33. Lindau-Shepard B., Roth K.E., Dias J.A. Identification of amino acids in the C-terminal region of human follicle-stimulating hormone (FSH) beta-subunit involved in binding to human FSH receptor. Endocrinology 1994, 135:1235-1240.
34. Lopez-Gimenez J.F., Canals M., Pediani J.D., Milligan G. The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol. Pharmacol. 2007, 71:1015-1029.
35. Maizels E.T., Cottom J., Jones J.C., Hunzicker-Dunn M. Follicle stimulating hormone (FSH) activates the p38 mitogen-activated protein kinase pathway, inducing small heat shock protein phosphorylation and cell rounding in immature rat ovarian granulosa cells. Endocrinology 1998, 139:3353-3356.
36. Maya-Nunez G., Janovick J.A., Conn P.M. Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression. Endocrine 2000, 13:401-407.
37. McElvaine A.T., Mayo K.E. A dominant-negative human growth hormone-releasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 2006, 147:1884-1894.
38. Milligan G. G protein-coupled receptor dimerisation: molecular basis and relevance to function. Biochim. Biophys. Acta 2007, 1768:825-835.
39. Milligan G. A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br. J. Pharmacol. 2008, 153(Suppl. 1):S216-S229.
40. Minegishi T., Nakamura K., Yamashita S., Omori Y. The effect of splice variant of the human luteinizing hormone (LH) receptor on the expression of gonadotropin receptor. Mol. Cell. Endocrinol. 2007, 260-262:117-125.
41. Murthy K.S., Makhlouf G.M. Identification of the G protein-activating domain of the natriuretic peptide clearance receptor (NPR-C). J. Biol. Chem. 1999, 274:17587-17592.
42. Nakamura K., Yamashita S., Omori Y., Minegishi T. A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. Mol. Endocrinol. 2004, 18:1461-1470.
43. Nechamen C.A., Dias J.A. Point mutations in follitropin receptor result in ER retention. Mol. Cell. Endocrinol. 2003, 201:123-131.
44. Nechamen C.A., Thomas R.M., Dias J.A. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol. Cell. Endocrinol. 2007, 260-262:93-99.
45. Ng G.Y., O'Dowd B.F., Lee S.P., Chung H.T., Brann M.R., Seeman P., George S.R. Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Commun. 1996, 227:200-204.
46. Okamoto T., Nishimoto I. Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 1992, 267:8342-8346.
47. Okuda-Ashitaka E., Sakamoto K., Ezashi T., Miwa K., Ito S., Hayaishi O. Suppression of prostaglandin E receptor signaling by the variant form of EP1 subtype. J. Biol. Chem. 1996, 271:31255-31261.
48. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454:183-187.
49. Pauwels P.J., Tardif S., Colpaert F.C. Differential signalling of both wild-type and Thr(343)Arg dopamine D(2short) receptor by partial agonists in a G-protein-dependent manner. Biochem. Pharmacol. 2001, 62:723-732.
50. Pawson A.J., Maudsley S., Morgan K., Davidson L., Naor Z., Millar R.P. Inhibition of human type 1 gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment. Endocrinology 2005, 146:2639-2649.
51. Pin J.P., Neubig R., Bouvier M., Devi L., Filizola M., Javitch J.A., Lohse M.J., Milligan G., Palczewski K., Parmentier M., Spedding M. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol. Rev. 2007, 59:5-13.
52. Richards J.S., Russell D.L., Ochsner S., Hsieh M., Doyle K.H., Falender A.E., Lo Y.K., Sharma S.C. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent. Prog. Horm. Res. 2002, 57:195-220.
53. Sairam M.R., Jiang L.G., Yarney T.A., Khan H. Follitropin signal transduction: alternative splicing of the FSH receptor gene produces a dominant negative form of receptor which inhibits hormone action. Biochem. Biophys. Res. Commun. 1996, 226:717-722.
54. Salahpour A., Angers S., Mercier J.F., Lagace M., Marullo S., Bouvier M. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J. Biol. Chem. 2004, 279:33390-33397.
55. Scarselli M., Novi F., Schallmach E., Lin R., Baragli A., Colzi A., Griffon N., Corsini G.U., Sokoloff P., Levenson R., Vogel Z., Maggio R. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem. 2001, 276:30308-30314.
56. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., Hofmann K.P., Ernst O.P. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455:497-502.
57. Seger R., Hanoch T., Rosenberg R., Dantes A., Merz W.E., Strauss J.F., Amsterdam A. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J. Biol. Chem. 2001, 276:13957-13964.
58. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 1997, 18:739-773.
59. Szidonya L., Cserzó M., Hunyady L. Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J. Endocrinol. 2008, 196:435-453.
60. Tao Y.X., Johnson N.B., Segaloff D.L. Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor. J. Biol. Chem. 2004, 279:5904-5914.
61. Thomas R.M., Nechamen C.A., Mazurkiewicz J.E., Muda M., Palmer S., Dias J.A. Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 2007, 148:1987-1995.
62. Timossi C., Maldonado D., Vizcaino A., Lindau-Shepard B., Conn P.M., Ulloa-Aguirre A. Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activation. Mol. Cell. Endocrinol. 2002, 189:157-168.
63. Timossi C., Ortiz-Elizondo C., Pineda D.B., Dias J.A., Conn P.M., Ulloa-Aguirre A. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor. Mol. Cell. Endocrinol. 2004, 223:17-26.
64. Uberti M.A., Hague C., Oller H., Minneman K.P., Hall R.A. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. J. Pharmacol. Exp. Ther. 2005, 313:16-23.
65. Ulloa-Aguirre A., Conn P.M. G protein-coupled receptors and the G protein family. Handbook of Physiology-Endocrinology: Section 7, Cellular Endocrinology 1998, 87-141. Oxford University Press, New York. P.M. Conn (Ed.).
66. Ulloa-Aguirre A., Timossi C. Structure-function relationship of follicle-stimulating hormone and its receptor. Hum. Reprod. Update 1998, 4:260-283.
67. Ulloa-Aguirre A., Janovick J.A., Brothers S.P., Conn P.M. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic 2004, 5:821-837.
68. Ulloa-Aguirre A., Uribe A., Zarinan T., Bustos-Jaimes I., Perez-Solis M.A., Dias J.A. Role of the intracellular domains of the human FSH receptor in G(alphaS) protein coupling and receptor expression. Mol. Cell. Endocrinol. 2007, 260-262:153-162.
69. Ulloa-Aguirre A., Zarinan T., Pasapera A.M., Casas-Gonzalez P., Dias J.A. Multiple facets of follicle-stimulating hormone receptor function. Endocrine 2007, 32:251-263.
70. Uribe A., Zarinan T., Perez-Solis M.A., Gutierrez-Sagal R., Jardon-Valadez E., Pineiro A., Dias J.A., Ulloa-Aguirre A. Functional and structural roles of conserved cysteine residues in the carboxyl-terminal domain of the follicle-stimulating hormone receptor in human embryonic kidney 293 cells. Biol. Reprod. 2008, 78:869-882.
71. Vassart G., Pardo L., Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem. Sci. 2004, 29:119-126.
72. Weiner R.S., Dias J.A. Biochemical analyses of proteolytic nicking of the human glycoprotein hormone alpha-subunit and its effect on conformational epitopes. Endocrinology 1992, 131:1026-1036.
73. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998, 396:679-682.
74. Wilson S., Wilkinson G., Milligan G. The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J. Biol. Chem. 2005, 280:28663-28674.
75. Wu D., Jiang H., Simon M.I. Different alpha 1-adrenergic receptor sequences required for activating different G alpha subunits of Gq class of G proteins. J. Biol. Chem. 1995, 270:9828-9832.
76. Zambrano E., Barrios-de-Tomasi J., Cardenas M., Ulloa-Aguirre A. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone. Mol. Hum. Reprod. 1996, 2:563-571.
77. Zhang M., Feng X., Guan R., Hébert T.E., Segaloff D.L. Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell. Signal. 2009, 21:1663-1671.
78. Zhou J., You Y., Zabner J., Ryan A.J., Mallampalli R.K. The CCT promoter directs high-level transgene expression in distal lung epithelial cell lines. Am. J. Respir. Cell Mol. Biol. 2004, 30:61-68.
79. Zhu X., Wess J. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 1998, 37:15773-15784.